Moderna Halts CMV and Birth Defects Vaccine Programs After Trial Failures
Moderna's experimental cytomegalovirus (CMV) vaccine failed in a Phase 3 trial, marking a significant setback for the company, which had high sales expectations for the vaccine prior to the failure amid ongoing pressures from Wall Street and the government.